semaglutide weight loss
Tirzepatide currently leads prescription weight-loss therapy, delivering up to 20% body-mass reduction in one year, compared with about 15% for semaglutide. This makes it the top choice for clinicians focused on rapid, sustainable weight loss. Did you know the average 9-to-5 worker can lose up to 7 lbs in the
semaglutide weight loss
In 2024, real-world data from 21,378 patients showed tirzepatide delivered a 15.2% average body weight loss after 72 weeks, making it the most consistent GLP-1 for cutting glucose and shedding pounds. While individual tolerability and cost matter, tirzepatide generally outperforms semaglutide and emerging oral options on both metrics.
semaglutide weight loss
Tirzepatide wins the current prescription weight-loss race, delivering superior outcomes over semaglutide and emerging oral agents. In 2026, head-to-head trials showed tirzepatide outperforming its competitors in average body-weight reduction. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional